February 2025
M	T	W	T	F	S	S
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28

Radiotherapy

Jan 25, 2025, 14:25

Radiotherapy vs. Chemotherapy: Differences And Similarities

Radiotherapy is a treatment that uses high-energy radiation to target and destroy cancer cells. It works by damaging the DNA of these rapidly growing cells, which prevents them from continuing to grow and divide. The radiation can be delivered in different ways, either externally or internally. External radiation involves directing radiation from outside the body toward the tumor. Internal radiation, also known as brachytherapy, places the radiation source directly inside or close to the tumor. Systemic radiation involves delivering the radiation through the bloodstream, often by injection or oral medication. Radiotherapy is commonly used to treat various types of cancer, either alone or in combination with other treatments such as chemotherapy or surgery. It may be the first line of treatment in some cases, particularly for early-stage cancers, or it can be used to shrink a tumor before surgery. In other cases, it may help manage symptoms, especially when cancer is advanced and cannot be cured. Like chemotherapy, radiotherapy can affect healthy cells along with the cancerous ones, leading to side effects such as fatigue, nausea, and skin issues. However, its main focus is on the tumor, making it particularly useful for cancers that are localized in specific areas. The decision to use radiotherapy depends on the type of cancer, its location, and how far it has spread.

What Is Chemotherapy?

Chemotherapy involves the use of powerful drugs to treat cancer by targeting and killing cells that divide and grow quickly. These drugs work by interfering with the cell’s ability to reproduce or function normally, which leads to cell death. Chemotherapy primarily targets cancer cells, but it can also affect other healthy cells in the body that divide rapidly, such as those in the hair follicles, digestive tract, and bone marrow.

Chemotherapy drugs come in various types, each with specific mechanisms of action. Antimetabolites disrupt the cell’s ability to synthesize DNA and RNA, which are essential for cell division and growth, thereby preventing cancer cells from multiplying. Alkylating agents damage the DNA in cancer cells, hindering their replication and slowing their growth, potentially causing the cells to die. Topoisomerase inhibitors interfere with enzymes that help unwind DNA, blocking the replication process in cancer cells. Mitotic inhibitors prevent cell division, effectively halting the multiplication of cancer cells.

Side Effects: Radiotherapy vs. Chemotherapy

Both radiation therapy and chemotherapy affect rapidly dividing cells, leading to side effects in healthy tissues as well as cancer cells. However, the nature, intensity, and long-term effects of these side effects differ between the two treatments.

Radiotherapy Side Effects

Radiation typically targets specific areas, so side effects are usually limited to the treatment site. For example, abdominal radiation can cause gastrointestinal symptoms such as nausea, vomiting, or diarrhea. Skin reactions, including dryness, irritation, and sores, are common in the treated area. Many patients also experience fatigue, which can persist for weeks after treatment. Hair loss is usually restricted to the treated area, and it often regrows after treatment. Long-term effects may include fibrosis, tissue changes, and a small risk of secondary cancers developing in the treated area over time.

Chemotherapy Side Effects

Chemotherapy affects the entire body, leading to widespread side effects such as nausea, vomiting, hair loss, and fatigue. It also weakens the immune system by reducing white blood cell production due to its impact on the bone marrow, increasing the risk of infections. Irritation of the digestive tract can cause issues like diarrhea, constipation, or mouth sores. Long-term effects may include damage to organs such as the heart, kidneys, or lungs, as well as nerve damage that can result in peripheral neuropathy.

Common Side Effects of Radiotherapy

Radiotherapy can cause side effects, varying by treatment area. Common effects include fatigue, often lasting weeks post-treatment, and skin reactions near the treated area, ranging from dryness to blisters. Hair loss occurs only in the treated region and may regrow. Radiation to the abdomen or pelvis can cause temporary nausea, vomiting, diarrhea, or appetite loss. Treated areas may experience pain or swelling, manageable with pain relief. Pelvic radiation may lead to urinary issues like frequent urination or blood in the urine. Radiation to the head or neck can cause dry mouth, difficulty swallowing, or sore throat. Rarely, radiation increases the risk of secondary cancers years later. Doctors provide guidance to manage these usually temporary effects.

Common Side Effects of Chemotherapy

Chemotherapy causes side effects by targeting both cancerous and fast-dividing healthy cells. Hair loss is common but temporary, with regrowth after treatment. Nausea and vomiting can occur, manageable with anti-nausea medication and diet changes. The immune system weakens due to reduced white blood cells, raising infection risk; good hygiene and avoiding crowds are advised. Fatigue is common and may persist, helped by rest, a healthy diet, and light exercise. Mouth sores can make eating difficult; oral hygiene, pain-relief rinses, and hydration provide relief. Digestive issues like diarrhea or constipation are managed with fluids, diet, and medications. Skin and nail changes, such as dryness or brittleness, benefit from moisturizing and gentle care. “Chemobrain,” or memory issues, is usually temporary and can improve with mental activities and stress management.

Costs: Radiotherapy vs. Chemotherapy

The costs associated with radiotherapy and chemotherapy can vary greatly, influenced by factors such as the type of cancer, treatment duration, and healthcare settings. Both treatments can be expensive, but the overall costs, insurance coverage, and out-of-pocket expenses differ between the two.

Wills et al. (2024), published in The European Journal of Health Economics, analyzed initial treatment costs for breast, colon, rectal, lung, and prostate cancers by stage. Costs increased with later-stage diagnoses for most cancers, except lung and prostate cancers, where costs were lower at stages 1 and 4 than at stages 2 and 3. Surgery and SACT were the most expensive treatments. Radiotherapy and SACT costs remained stable across stages 1–3, with radiotherapy costs decreasing and SACT costs increasing at stage 4. These findings highlight the importance of stage-specific cost estimation for cancer service planning.

Ara et al. (2024) from the University of Sheffield conducted a rapid review on the cost-effectiveness of surgical and radiotherapy interventions in breast, colorectal, prostate, cervical, and head and neck cancers. The review included 45 studies evaluating incremental cost per quality-adjusted life year (QALY) in line with NICE guidelines. Whole breast radiotherapy and post-mastectomy radiotherapy for breast cancer were generally cost-effective, while partial breast radiotherapy remained experimental. Preoperative radiotherapy and laparoscopic surgery showed cost-effectiveness for colorectal cancer in specific scenarios. For prostate cancer, intensity-modulated radiotherapy and brachytherapy were cost-effective, but radical prostatectomy was dominated by watchful waiting. No cervical cancer studies met the inclusion criteria, and for head and neck cancer, proton therapy and advanced radiotherapy techniques were cost-effective. Limitations included few UK-based studies, dated evidence, and limited applicability of international cost data to UK settings.

Varmaghani et al. (2023), published in BMC, estimated the total costs of IMRT and 3D-CRT at $13,761 and $10,150 per person, respectively. The largest expense for both was direct medical costs, with IMRT at $13,363 compared to $9,772 for 3D-CRT. IMRT also incurred higher direct non-medical costs ($103 vs. $80), while absenteeism-related productivity costs were similar ($294 for IMRT and $296 for 3D-CRT).

Chemotherapy Costs

Chemotherapy is often more affordable than radiotherapy but can become costly due to drug expenses, multiple cycles, and managing side effects. It is typically well-covered by insurance, including medications and hospital visits, though coverage varies by plan and cancer type. Patients may still face out-of-pocket costs like co-pays and deductibles, which can be significant for those without insurance or with high-deductible plans. Financial assistance is available through pharmaceutical companies, non-profits, government programs, and hospital counseling services to help manage costs.

Sohi et al. (2021), published in The European Journal of Health Economics, conducted a systematic review and meta-analysis to estimate the direct costs of outpatient intravenous chemotherapy administration. Analyzing 44 studies, including 19 from the US and seven from Canada, they reported a median cost of $142/hour (IQR $103–166) globally, with US costs at $149/hour (IQR $118–158) and Canadian costs at $128/hour (IQR $102–137). Physician fees were the most commonly reported cost component. Variability in cost estimates reflects differences in regional analysis, cost inclusivity, and unit price methodologies.

Which Treatment Is Right for You?

Choosing between radiotherapy and chemotherapy for cancer treatment involves considering several key factors such as the type of cancer, its stage, and the patient’s overall health. Both treatments have distinct characteristics, and the decision should be based on how each approach aligns with the specific circumstances of the patient.

Cancer Type

It works by targeting cells throughout the body, which is why it’s useful for cancers that have already metastasized. Radiotherapy, however, is typically more suited for localized cancers or those confined to a specific area. It’s often used for tumors that are well-defined and can be targeted directly, such as in prostate, breast, or head and neck cancers. Radiation can also be effective for certain cancers that are resistant to chemotherapy or when chemotherapy alone isn’t enough.

A review of 18 studies (6521 men) by Wang et al., published in Clinical and Translational Radiation Oncology in 2023, showed that IGRT significantly reduced acute GU toxicity (RR, 0.78; P < 0.001), GI toxicity (RR, 0.49; P < 0.001), and late GI toxicity (HR, 0.25; P = 0.03) compared to non-IGRT. Daily IGRT improved 3-year PRFS (HR, 0.45; P = 0.001) and BFFS (HR, 0.57; P = 0.003), with high-frequency IGRT offering greater benefits than weekly IGRT. However, IGRT did not significantly affect 5-year OS or SCM. IGRT improves biochemical tumor control and reduces GI and GU toxicity in prostate radiotherapy but does not improve long-term survival outcomes.

Stage of Cancer

For early-stage cancers, radiotherapy is often used either as a primary treatment to eliminate the tumor or as a complementary treatment after surgery to ensure that any remaining cancer cells are destroyed. Radiation is also effective in shrinking tumors before surgery, making it easier to remove them. Chemotherapy is commonly used for advanced cancers or when the cancer has spread beyond its initial location. Chemotherapy can target cancer cells throughout the body, which makes it ideal for cancers that have metastasized or are not confined to one area.

Combination of Treatments

In some cases, doctors may recommend using both radiotherapy and chemotherapy together. This approach may be beneficial when chemotherapy can treat cancer that has spread beyond the radiation zone while radiation targets localized tumors. This combined approach may increase the chances of curing the cancer or controlling its growth. By combining these modalities, this treatment strategy can offer several potential benefits. It may increase the likelihood of curing the cancer, particularly in cases where a single treatment alone would not be sufficient. For example, in cancers such as cervical, lung, or head and neck cancer, anal cancer this approach has been shown to improve local tumor control and reduce the risk of recurrence. Additionally, combining radiotherapy and chemotherapy may help shrink tumors more effectively, making them easier to surgically remove or manage.

In locally advanced cervical cancer, cisplatin-based CRT is the standard treatment, offering superior disease-free survival compared to neoadjuvant chemotherapy followed by surgery. CRT carries higher risks of toxicities, but these are not significantly different over time, except for vaginal toxicity. Patients can be stratified into high-risk or low-risk groups based on factors like tumor size and lymph node involvement. Rallis et al., published in Anticancer Research, 2021.

CRT with fluorouracil and mitomycin C has been the mainstay treatment for anal squamous cell carcinomas since the 1970s, offering organ preservation and improved local control. High-dose brachytherapy can further improve local control in patients with residual disease, and IMRT enhances precision without treatment gaps. However, IMRT benefits do not necessarily translate to improved overall survival. Rallis et al., published in Anticancer Research, 2021.

Making the Right Decision

The decision to use radiotherapy or chemotherapy is complex and should be made in consultation with an oncologist. This decision will depend on the cancer’s type, stage, the patient’s general health, and personal preferences regarding side effects. Patients should consider the goals of treatment, such as whether the priority is to eliminate a localized tumor or to manage cancer that has spread. Understanding the potential side effects and long-term impacts on health is also crucial in making an informed decision.

Ultimately, the treatment plan should be personalized to suit the individual’s needs, balancing effectiveness with quality of life considerations. The oncologist will play a key role in explaining the pros and cons of each approach, helping patients choose the best treatment strategy. make liitle bit short but keep this form

radiation oncologist

Learn More About Who is Radiation Oncologist by Special Article on OncoDaily

Factors to Consider

When deciding between radiotherapy and chemotherapy, there are several factors to consider. These include the patient’s overall health, the treatment goals (whether curative or palliative), and the specific characteristics of the cancer being treated. Each factor plays a crucial role in determining the most appropriate treatment strategy.

A patient’s general health and ability to tolerate treatment are critical in this decision. For patients with pre-existing health conditions, such as heart disease or lung problems, radiotherapy may be preferred because it tends to have more localized side effects. It’s a more targeted approach, which might be more manageable for those who cannot tolerate the broader effects of chemotherapy. Chemotherapy, being a systemic treatment, may be harder to tolerate, especially for individuals with weakened immune systems, severe fatigue, or other complicating factors. The broader side effects like nausea, hair loss, and immune suppression can be more taxing on a patient’s overall health.

For patients whose goal is to completely eliminate the cancer, chemotherapy is o used when the cancer is widespread or metastasized. It is effective for cancers that are not confined to a single location, like leukemia or lymphoma. In some cases, radiotherapy may be used to target and shrink localized tumors, making it a suitable choice for cancers that have not spread. Palliative Goals: When the goal is to relieve symptoms rather than cure the disease, radiotherapy may be used to shrink tumors causing pain, pressure, or obstruction. It’s often effective in providing relief in advanced cancer stages where a cure is no longer possible. Chemotherapy might still be an option if it can help slow the cancer’s progression, but it can also cause additional side effects that may diminish the patient’s quality of life.

Written by Aren Karapetyan, MD

FAQ

Can chemotherapy and radiotherapy be combined?

Yes, chemotherapy and radiotherapy can be used together depending on the cancer type and stage. This combination may increase the effectiveness of treatment, although side effects could be more severe when used in tandem.

What are the latest advancements in chemotherapy?

Recent advancements in chemotherapy include improved drug formulations, targeted therapies, and combinations with other treatments like immunotherapy and radiotherapy to enhance effectiveness and reduce side effects.

How do chemotherapy and radiotherapy differ in terms of treatment delivery?

Chemotherapy is typically administered through intravenous infusion or oral medications, whereas radiotherapy is delivered either externally or internally to the tumor site.

What are the primary goals of chemotherapy?

Chemotherapy aims to kill rapidly dividing cancer cells, shrink tumors, and prevent the spread of cancer, with the potential for curative or palliative outcomes.

Can chemotherapy cause permanent hair loss?

Chemotherapy often causes temporary hair loss due to its impact on rapidly dividing cells, but hair typically regrows after treatment ends.

Is radiotherapy suitable for all types of cancer?

Radiotherapy is effective for many cancers, especially localized ones, but its applicability depends on the cancer type, location, and stage.

What are the main side effects of chemotherapy?

Common side effects include fatigue, nausea, vomiting, hair loss, weakened immune system, and gastrointestinal issues like diarrhea.

How does radiation therapy impact healthy tissues?

Radiation therapy can affect both healthy and cancerous tissues. While it targets the tumor, surrounding healthy tissue can also be affected, leading to side effects like skin irritation or fatigue.

Can radiotherapy cure cancer?

Radiotherapy may cure certain types of cancer, especially if the cancer is localized, but it may also be used to shrink tumors or manage symptoms in more advanced cases.